Rabbit polyclonal Antibody to Bevacizumab/Avastin
Catalogue Number: 45-1112-ABO
| Manufacturer: | Abeomics |
| Type: | Polyclonal Primary Antibody - Unconjugated |
| Shipping Condition: | Blue Ice |
| Unit(s): | 40 ug |
| Host name: | Rabbit |
| Clone: | |
| Isotype: | |
| Immunogen: | Bevacizumab |
| Application: | ELISA |
Description
Description: Bevacizumab (Avastin) is a humanized polyclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As angiogenesis inhibitor, Bevacizumab blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A). Anti-Bevacizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Bevacizumab.
Additional Text
Purification
Affinity Purified
Antibody Clonality
Polyclonal
Application Notes
ELISA detection: 0.05-0.2 µg/ml
45-1112 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations